Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNJ5 encodes an inward-rectifier potassium channel subunit primarily expressed in the adrenal gland and pituitary. It plays a crucial role in maintaining resting membrane potential and regulating cellular excitability. Mutations in KCNJ5 can disrupt ion selectivity, leading to sodium influx, cellular depolarization, and dysregulation of calcium signaling. These alterations can result in diseases like aldosterone-producing adenomas, familial hyperaldosteronism type III, and Long QT syndrome type 13.
Modulation of potassium ion flow; influencing cell membrane potential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium Inwardly Rectifying Channel Subfamily J Member 5 (KCNJ5).